Indraprastha Medical Corporation Limited (INDRAMEDCO.NS)
INR 500.05
(-0.28%)
INR 500.05
(-0.28%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 322.7 Million INR | 0.0% |
| 2022 | - INR | -100.0% |
| 2021 | 24.8 Million INR | -53.24% |
| 2020 | 53.04 Million INR | -32.16% |
| 2019 | 78.18 Million INR | -47.88% |
| 2018 | 150 Million INR | -28.57% |
| 2017 | 210 Million INR | 0.0% |
| 2016 | - INR | -100.0% |
| 2015 | 24.99 Million INR | -76.92% |
| 2014 | 108.33 Million INR | -58.06% |
| 2013 | 258.33 Million INR | -13.04% |
| 2012 | 297.08 Million INR | 6.58% |
| 2011 | 278.75 Million INR | -62.85% |
| 2010 | 750.24 Million INR | 156.16% |
| 2009 | 292.88 Million INR | -40.56% |
| 2008 | 492.7 Million INR | -23.77% |
| 2007 | 646.34 Million INR | 20.54% |
| 2006 | 536.21 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 0.0% |
| 2024 Q2 | - INR | 0.0% |
| 2023 Q4 | 322.7 Million INR | 0.0% |
| 2023 FY | 322.7 Million INR | 0.0% |
| 2023 Q1 | - INR | 0.0% |
| 2023 Q2 | 31 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 8.4 Million INR | 0.0% |
| 2022 Q4 | - INR | 0.0% |
| 2021 Q2 | 39.6 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 24.8 Million INR | -53.24% |
| 2021 Q4 | 24.8 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 86.16 Million INR | 0.0% |
| 2020 FY | 53.04 Million INR | -32.16% |
| 2020 Q4 | 53.04 Million INR | 0.0% |
| 2019 Q2 | 60 Million INR | 0.0% |
| 2019 Q4 | 78.18 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 78.18 Million INR | -47.88% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 150 Million INR | -28.57% |
| 2018 Q4 | 150 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 180 Million INR | 0.0% |
| 2017 FY | 210 Million INR | 0.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 Q2 | 240 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 210 Million INR | 0.0% |
| 2016 FY | - INR | -100.0% |
| 2016 Q2 | - INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | 0.0% |
| 2016 Q4 | - INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 50 Million INR | 0.0% |
| 2015 FY | 24.99 Million INR | -76.92% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 25 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 108.33 Million INR | -58.06% |
| 2014 Q4 | 108.33 Million INR | 0.0% |
| 2014 Q2 | 216.66 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 258.33 Million INR | -13.04% |
| 2013 Q4 | 258.33 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 350 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 409.16 Million INR | 0.0% |
| 2012 FY | 297.08 Million INR | 6.58% |
| 2012 Q4 | 297.08 Million INR | 0.0% |
| 2011 FY | 278.75 Million INR | -62.85% |
| 2010 FY | 750.24 Million INR | 156.16% |
| 2009 FY | 292.88 Million INR | -40.56% |
| 2008 FY | 492.7 Million INR | -23.77% |
| 2007 FY | 646.34 Million INR | 20.54% |
| 2006 FY | 536.21 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 22.35 Billion INR | 98.557% |
| Artemis Medicare Services Limited | 2.27 Billion INR | 85.829% |
| Aster DM Healthcare Limited | 4.46 Billion INR | 92.766% |
| Fortis Healthcare Limited | 7.4 Billion INR | 95.644% |
| HealthCare Global Enterprises Limited | 10.44 Billion INR | 96.909% |
| Krishna Institute of Medical Sciences Limited | 9.27 Billion INR | 96.521% |
| Lotus Eye Hospital and Institute Limited | 6.88 Million INR | -4586.32% |
| Max Healthcare Institute Limited | 10.6 Billion INR | 96.958% |
| Max India Limited | 8.19 Million INR | -3835.366% |
| Global Health Limited | 6.29 Billion INR | 94.878% |
| Narayana Hrudayalaya Limited | 13.44 Billion INR | 97.6% |
| Rainbow Children's Medicare Limited | 7.48 Billion INR | 95.688% |
| Shalby Limited | 1.75 Billion INR | 81.662% |